Anti-Wrinkle Treatment Melbourne

anti-wrinkle treatment at Core Aesthetics in Oakleigh uses prescription injectable products to temporarily reduce muscle activity in specific facial areas, softening expression lines while preserving natural movement. All treatment is individually assessed by Corey Anderson, AHPRA registered nurse, at a consultation before any recommendation is made. The clinic serves clients from across Melbourne’s south east and inner suburbs from 12A Atherton Road, Oakleigh VIC 3166.

What Anti-Wrinkle Treatment Involves

anti-wrinkle injectable treatment uses a prescription product to temporarily block the signal between a nerve and a specific facial muscle at the injection site. This reduces the muscle’s contractile force, which softens the expression lines driven by that movement. The effect is not permanent. Muscle activity returns gradually over three to four months as the product is metabolised.

What individual assessment determines

“The best result is the one where people notice you look well, not that you have had treatment.”

At Core Aesthetics, the assessment determines which specific muscles to treat, what dose is appropriate for the individual anatomy and what result is realistic. A conservative first treatment is always the starting point. Overtreating in a single session is one of the most common causes of an unnatural result, and a more cautious approach that can be built on at review consistently produces better outcomes than a heavy first treatment.

Areas Treated at Core Aesthetics

Not all areas are appropriate for every client. Corey assesses the full face at consultation and recommends only what is clinically appropriate for the individual anatomy and presenting concern.

The Consultation at Core Aesthetics

Every anti-wrinkle treatment at Core Aesthetics begins with an individual consultation with Corey Anderson. He will take a thorough medical history, assess your facial anatomy directly and discuss your concerns and goals. The recommendation you receive is based entirely on this assessment, not on a standard protocol applied to every client.

What happens in the appointment

There is no obligation to proceed following consultation. Many clients find the consultation valuable in itself, it gives a clear understanding of what treatment can realistically achieve for their individual face before any decision is made.

Read more about what to expect at a cosmetic injectables consultation and about what first time clients can expect from anti-wrinkle treatment.

Why Core Aesthetics for Anti-Wrinkle Treatment in Melbourne

Core Aesthetics is a sole practitioner clinic. Corey Anderson assesses and treats every client personally for every appointment. There is no junior practitioner, no variation in the standard of care between visits and no handoff between the consultation and the treatment. The same experienced clinician is present throughout.

Corey has held continuous AHPRA nursing registration since January 1996. His registration is publicly verifiable at coreaesthetics.com.au/verify. All prescription injectable treatments are assessed and administered in compliance with TGA regulations and AHPRA practitioner guidelines. Read about patient safety at Core Aesthetics and the AHPRA guidelines for cosmetic injectables.

Serving the area from Oakleigh

Core Aesthetics is at 12A Atherton Road, Oakleigh VIC 3166, centrally located to serve our city’s south east, inner east and inner west suburbs. The clinic is accessible from Carnegie, Chadstone, Bentleigh, Clayton, Malvern, Caulfield, Brighton, Toorak, South Yarra, Camberwell and across Victoria. Oakleigh station on the Cranbourne and Pakenham lines is a short walk from the clinic. Open Tuesday to Saturday by appointment.

Related: Read more about anti-wrinkle treatment at Core Aesthetics and book a consultation at Core Aesthetics, Oakleigh.

General Information Only. This article is general in nature and does not replace a consultation with a qualified health practitioner. Treatment outcomes, suitability and risks vary by individual. Any medical or prescription treatment options can only be discussed and provided where clinically appropriate following an individual assessment.

Safety, Suitability and Clinical Assessment

All cosmetic injectable procedures carry risk. The suitability assessment at consultation identifies any contraindications or relative risk factors specific to your circumstances, including medical history, current medications, previous procedures, and anatomical features that may affect the risk profile for a given treatment area. This information is reviewed before any treatment is planned.

For certain conditions and medications, injectable treatments are not appropriate, or require modification of technique or timing. For others, the treating practitioner may recommend that you consult with your primary healthcare provider before proceeding. These are clinical judgements that can only be made with accurate, complete medical history information, which is why the consultation history taking process is thorough.

Complication recognition and initial management are part of the clinical competency required of practitioners performing injectable treatments under AHPRA’s September 2025 guidelines for nonsurgical cosmetic procedures. The practitioner at Core Aesthetics holds current training in this area and maintains the relevant management supplies on site. Understanding that risk exists and is actively managed is more useful than assuming procedures carry no risk.

What the Assessment Covers

The assessment at the consultation appointment is a face wide evaluation, not a focused review of only the area you have identified as a concern. This full face approach is deliberate: anatomical features interact with each other, and addressing one area in isolation, without understanding the broader facial context, can produce results that look disproportionate even when the individual area was technically treated well.

The practitioner evaluates facial symmetry, bone structure, soft tissue distribution, skin quality, and the dynamic movement patterns associated with each treatment area. The history taking covers your current medications, any previous injectable or surgical procedures, relevant health conditions, and any prior reactions or complications. From this assessment, the practitioner develops a treatment plan that reflects your specific anatomy and circumstances.

Results vary between individuals. What the assessment finds in one patient may be different from what it finds in another patient with a similar presenting concern, which is why templated treatment protocols are not used here. All treatments at Core Aesthetics are consultation-based and individually assessed.

Understanding How anti-wrinkle Treatment Works at a Cellular Level

anti-wrinkle treatment uses a prescription injectable that temporarily interrupts the signal between the nerve and the muscle. The active substance blocks the release of acetylcholine at the neuromuscular junction, the chemical messenger that triggers muscle contraction. Without this signal, the targeted muscle relaxes. The skin above it, no longer creased by repeated movement, gradually softens.

This effect is temporary because the body regenerates the nerve terminals that were blocked. Axonal sprouting, the regrowth of nerve endings, is the mechanism by which muscle activity slowly returns, typically over three to five months. The pace of recovery varies between individuals and between treatment areas.

Understanding this mechanism matters for treatment planning. anti-wrinkle treatment works on muscles. It does not replace volume, improve skin texture, or address structural concerns. For lines that are visible at rest, not just during expression, a different assessment is needed, and filler or other approaches may be more appropriate.

The Role of Facial Mapping in anti-wrinkle Treatment

Effective anti-wrinkle treatment begins with a detailed understanding of how a specific person’s face moves. The same treatment applied to two different people can produce very different outcomes because the underlying anatomy, muscle size, attachment points, the relationship between muscles, varies considerably from person to person.

At Core Aesthetics, the pretreatment assessment includes observing movement patterns, identifying which muscles are contributing to the lines of concern, and understanding how treatment in one area might influence adjacent muscles. For example, treating the forehead without accounting for the brow position can produce a result that looks heavy or drops the brow unexpectedly. Treatment planning that ignores these relationships is a common source of dissatisfaction.

Facial mapping is not a visual tool, it is a clinical one. The goal is to understand function, not just appearance. A treatment plan designed around function is more likely to produce a result that looks natural and balanced, because it works with how the face moves rather than simply suppressing whatever is visible.

What Results Can Realistically Be Expected

anti-wrinkle treatment is effective at softening dynamic lines, lines that appear during expression. For most people, consistent treatment over time produces a visible reduction in the depth of these lines even at rest, as the skin is given repeated periods of reduced mechanical stress.

However, there are realistic limits. Lines that have been present for many years and are deeply etched into the skin may not fully resolve with anti-wrinkle treatment alone. Very deep static lines, visible without any movement, often require additional approaches, which are discussed at consultation. anti-wrinkle treatment cannot restore lost volume, improve skin quality, or address structural changes associated with ageing.

Results vary between individuals. Factors that influence outcomes include muscle mass and activity, metabolic rate, skin quality, and the specific area treated. At Core Aesthetics, results are reviewed at a follow-up appointment at four to six weeks to assess the outcome and determine whether any adjustment is appropriate.

Safety, Complications, and Clinical Oversight

anti-wrinkle treatments are among the most extensively studied injectable treatments in cosmetic medicine. Serious adverse events are rare when treatment is performed by a trained, registered practitioner working within a clinical framework. The most common side effects are minor and temporary: bruising, redness, or tenderness at injection sites.

More significant complications, such as ptosis (drooping of the eyelid or brow), asymmetry, or an overcorrected result, do occur and are related to dose, placement, and individual anatomy. These risks are explained at consultation, documented in the consent process, and managed at the follow-up appointment if they arise. At Core Aesthetics, Corey provides emergency contact protocols and clear instructions for who to contact if a concern develops between appointments.

Certain health conditions and medications affect suitability for anti-wrinkle treatment. A full medical history review is part of every consultation. Treatment is not offered where there is clinical uncertainty about safety, and patients are referred to their treating doctor when appropriate.

long-term Planning and Treatment Intervals

Cosmetic injectable treatment is not a one time intervention for most people. anti-wrinkle treatment wears off over time, and maintaining the result requires repeat appointments. Understanding what this looks like over months and years is part of what the consultation is designed to establish.

Most people find that anti-wrinkle treatment lasts three to five months before movement noticeably returns. Some find that regular treatment over time allows longer intervals between appointments, as the muscle is treated repeatedly, the pattern of activity can change. Others maintain a consistent interval throughout. Neither pattern is better or worse; it reflects individual variation.

At Core Aesthetics, treatment intervals are discussed at the consultation and reassessed at each visit. There is no expectation that patients will come at any set frequency, the appointment cycle is determined by clinical outcome and individual need, not by a service schedule.

How Treatment Decisions Are Made Across The Upper Face

Anti-wrinkle treatment of the upper face addresses three muscle groups that work in concert: the frontalis (forehead), the corrugator and procerus complex (the glabellar ‘eleven’ lines), and the lateral orbicularis oculi (the lateral periorbital lines, often called crow’s feet). Treating any of the three in isolation without considering the others can shift the balance of expression in ways that read as unnatural, because the muscles compensate for each other dynamically.

The frontalis is the primary lifter of the brow. Treating it too aggressively, particularly in patients who use frontal lift to support a heavy brow position, can produce a sense of brow heaviness and visible forehead static lines that the patient may find more aesthetically problematic than the original dynamic lines. Conservative dosing in this region is the default. The corrugator and procerus group create vertical and horizontal lines between the brows; they are typically treated more aggressively than the frontalis because the visible movement is rarely missed and because the muscle’s contractile pattern is more localised. The lateral orbicularis oculi is treated with attention to the relationship between the dose and the patient’s smile dynamics; over-treatment here can flatten the smile in a way that reads as unfamiliar to the patient and the people who know them.

Onset is gradual. The clinical effect develops over five to ten days and stabilises by the two-week review. Duration is individual and depends on muscle mass, metabolism, dose, and the consistency of the treatment cycle. Most patients are reviewed at six to eight weeks for a first treatment and at twelve to fourteen weeks for established treatment plans, though the interval varies. Re-treatment cadence is set by the documented response, not by a calendar.

The conservative-dosing principle is applied at every appointment. The intent is to under-treat at first and adjust upward at the two-week review where the assessment supports it, rather than to maximise change in a single session and accept that any over-treatment must be waited out. This is structurally different from a maximalist treatment philosophy and produces different long-term outcomes. Treatment is performed by Corey Anderson, Registered Nurse, AHPRA NMW0001047575.

Treatment Cadence Across Years Of Continuous Care

Patients who begin anti-wrinkle treatment in their late twenties or early thirties and maintain a continuous treatment relationship across a decade typically describe an evolving treatment cadence rather than a static one. The first one or two cycles are foundational: dose ranges are established for each region, the patient’s individual response pattern is documented, and the conservative-dosing principle is operationalised through the two-week review and the dose adjustments that follow.

By the third or fourth cycle most patients have a stable understanding of their preferred re-treatment timing for each region, and the cadence becomes more individualised. Some patients find that the upper-face regions can be re-treated less frequently than the corrugator and procerus complex; some find the reverse. The two-week review remains the standard touchpoint at the start of any new dose range or after any change in the treatment plan, and the longer-cycle review (typically twelve to fourteen weeks for established patients) becomes the planning point for the next cycle.

Across years of continuous treatment, the cumulative effect on muscle mass and on the formation of static lines is meaningful but slow. Patients who have been treated consistently for several years often have measurably less static line formation in the treated regions than patients who began treatment later, even at comparable ages. This is one of the reasons why early establishment of a treatment relationship can produce different long-term outcomes than a reactive approach that begins only when static lines have already formed. The clinical literature supports this trajectory across multiple treatment cycles.

Patients who have not been treated for over twelve months are functionally new patients again at re-presentation. The dose ranges may need re-establishment, the response pattern may have shifted, and the conservative-dosing principle resets to the foundational position. This is a normal feature of re-engagement after a treatment gap rather than a disadvantage.